Does VENETOCLAX Cause Squamous cell carcinoma? 108 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 108 reports of Squamous cell carcinoma have been filed in association with VENETOCLAX (Venclexta). This represents 0.2% of all adverse event reports for VENETOCLAX.
108
Reports of Squamous cell carcinoma with VENETOCLAX
0.2%
of all VENETOCLAX reports
7
Deaths
15
Hospitalizations
How Dangerous Is Squamous cell carcinoma From VENETOCLAX?
Of the 108 reports, 7 (6.5%) resulted in death, 15 (13.9%) required hospitalization, and 5 (4.6%) were considered life-threatening.
Is Squamous cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VENETOCLAX. However, 108 reports have been filed with the FAERS database.
What Other Side Effects Does VENETOCLAX Cause?
Death (9,412)
Off label use (6,252)
Neutropenia (3,041)
Febrile neutropenia (2,663)
Platelet count decreased (2,367)
Pyrexia (2,351)
Pneumonia (2,300)
Fatigue (2,281)
Diarrhoea (2,082)
White blood cell count decreased (1,913)
What Other Drugs Cause Squamous cell carcinoma?
ADALIMUMAB (456)
RUXOLITINIB (413)
TACROLIMUS (327)
INFLIXIMAB (313)
RITUXIMAB (313)
LENALIDOMIDE (304)
PREDNISONE (267)
RANITIDINE (260)
CYCLOSPORINE (254)
METHOTREXATE (252)
Which VENETOCLAX Alternatives Have Lower Squamous cell carcinoma Risk?
VENETOCLAX vs VENLAFAXINE
VENETOCLAX vs VENTAVIS
VENETOCLAX vs VENTOLIN
VENETOCLAX vs VENTOLIN HFA
VENETOCLAX vs VERAPAMIL